STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
Recipharm will publish its interim report for January-March 2016 on 28 April at 07:45 am CET.
The company invites investors, analysts and media to a web conference (in English) on 28 April at 10:00 am CET, where CEO Thomas Eldered and CFO Björn Westberg will present and comment on the report as well as answer questions.
